Navigation Links
Menstrual Bleeding Treatment Safer Than Thought
Date:1/23/2009

Ablation technique is a less invasive alternative to hysterectomy, researchers note

FRIDAY, Jan. 23 (HealthDay News) -- Far fewer women than previously thought need additional surgery to stop excessive or prolonged menstrual bleeding after undergoing an alternative to hysterectomy called global endometrial ablation (GEA), a new study finds.

GEA, a relatively new procedure, has been regarded as being just as effective as hysterectomies while being less invasive with slightly lower complication rates and costs. During the surgery, heat, cold, microwave or radiofrequency energy is used to destroy only the uterine lining while keeping the uterus intact. Scar tissue then forms and monthly menstrual flow and its pain typically decrease.

The Mayo Clinic study, published in the January issue of Obstetrics and Gynecology, found that about 16 percent -- nearly half of past estimates -- of women required a hysterectomy to treat excessive bleeding in the first five years following an ablation.

"We've known for the past five to six years that global endometrial ablation devices are very effective," Mayo Clinic gynecologic surgeon Abimbola Famuyide, one of the study's authors, said in a news release issued by the facility. "But some physicians have observed that up to 30 percent of patients may require additional treatment five years and beyond after undergoing ablation."

More susceptible to a lack of permanent symptom relief, according to the the team, were GEA patients younger than 45 who had a tubal ligation to prevent pregnancy or had debilitating menstrual pain prior to the procedure.

Excessive or prolonged menstrual bleeding affects an estimated one in five women at some time in their lives, often during the onset of menopause.

The low failure rate, the researchers suggested, might also mean that the study sample contained many patients properly counseled to have realistic expectations for the procedure and symptom relief. "For example, patients who are seeking complete cessation of menstrual bleeding after GEA are more likely to undergo hysterectomy later to treat bleeding symptoms of any severity," Famuyide said.

The team also noted that previous studies of GEA failure were small or imprecise in defining failure. The Mayo team studied the medical records of more than 800 women had GEA procedures over an eight-year period.

More information

The National Women's Health Resource Center has more about menstrual disorders.



-- Kevin McKeever



SOURCE: Mayo Clinc, news release, Jan. 6, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Mayo researchers offer new insight into effectiveness of procedure to stop heavy menstrual bleeding
2. Taking Control: Future Therapies for a Host of Serious Diseases May Be Found in Womens Menstrual Blood
3. Complementary medicines can help mild depression and premenstrual syndrome
4. Delayed Sleep Pattern Tied to Irregular Menstrual Cycles
5. Safe to Stop the Flow?: Differing Attitudes Found Between Women and Doctors Concerning Menstrual Suppression
6. Differing attitudes found between women and doctors concerning menstrual suppression
7. MRI Scans Reveal Post-Heart Attack Bleeding
8. Bleeding hearts revealed with new scan
9. CSL Behring Receives FDA Approval of RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
10. Steroid After Tonsillectomy Raises Bleeding Risk
11. Study identifies double-balloon enteroscopy as cost-effective approach for obscure GI bleeding
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Menstrual Bleeding Treatment Safer Than Thought
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class ... support to bring their novel lifesaving device for the everyday use of parents ... sensors, specially designed to read a child’s vital signs, and detect unusual symptoms ...
(Date:4/24/2017)... Ill., and Waycross, Ga. (PRWEB) , ... April ... ... market leader and trusted advisor within the telehealth industry, announces the company’s VideoMedicine ... U.S. board-certified primary care providers. Available 24 hours a day, Quick Care provides ...
(Date:4/24/2017)... ... April 24, 2017 , ... According ... overdose deaths now claim the lives of 62 Americans each day.(1) Yet since ... drug manufacturers, distributors, pharmacies and prescribers by more than half.(2) Novus Medical ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... recognize elevated anxiety levels in people with addiction who are served by MAP’s ... a biosensing wearable device that monitors heart and breath rates to identify anxiety ...
(Date:4/24/2017)... ... 2017 , ... Pitavastatin, a relatively new statin, has relevance ... to have significant interactions with antiretroviral therapy (ART). Among people living with ... inflammation in the bloodstream. , While lowering cholesterol and dampening inflammation are beneficial ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017 NeuroVive Pharmaceutical AB ... announced positive preclinical results demonstrating anti-fibrotic effects ... non-alcoholic steatohepatitis (NASH), in an additional well-validated ... NV556 has previously shown similar anti-fibrotic effects ... NeuroVive,s scientists present novel data demonstrating anti-fibrotic ...
(Date:4/19/2017)...  IRIDEX Corporation (Nasdaq: IRIX ) today ... first quarter 2017 after the close of trading on ... host a corresponding conference call beginning at 2:30 p.m. ... in listening to the conference call may do so ... 326-3030 for international callers, using conference ID: 92158987.  A ...
(Date:4/19/2017)... 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... company developing new treatments for cancer and other ... its previously announced underwritten public offering of 23,625,084 ... offering price of $2.00 per share, before deducting ... payable by Sorrento.  The net proceeds to Sorrento ...
Breaking Medicine Technology: